Search by Drug Name or NDC
NDC 60505-2850-09 Alfuzosin Hydrochloride 10 mg/1 Details
Alfuzosin Hydrochloride 10 mg/1
Alfuzosin Hydrochloride is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is ALFUZOSIN HYDROCHLORIDE.
MedlinePlus Drug Summary
Alfuzosin is used in men to treat symptoms of an enlarged prostate (benign prostatic hyperplasia or BPH), which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency. Alfuzosin is in a class of medications called alpha blockers. It works by relaxing the muscles in the prostate and bladder to allow urine to flow more easily.
Related Packages: 60505-2850-09Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Alfuzosin
Product Information
| NDC | 60505-2850 |
|---|---|
| Product ID | 60505-2850_3659a5a6-5ddb-580e-debc-993b44879f2b |
| Associated GPIs | 56852010107530 |
| GCN Sequence Number | 045052 |
| GCN Sequence Number Description | alfuzosin HCl TAB ER 24H 10 MG ORAL |
| HIC3 | Q9B |
| HIC3 Description | BENIGN PROSTATIC HYPERTROPHY/MICTURITION AGENTS |
| GCN | 92024 |
| HICL Sequence Number | 010802 |
| HICL Sequence Number Description | ALFUZOSIN HCL |
| Brand/Generic | Generic |
| Proprietary Name | Alfuzosin Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Alfuzosin Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/1 |
| Substance Name | ALFUZOSIN HYDROCHLORIDE |
| Labeler Name | Apotex Corp. |
| Pharmaceutical Class | Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA079013 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60505-2850-09 (60505285009)
| NDC Package Code | 60505-2850-9 |
|---|---|
| Billing NDC | 60505285009 |
| Package | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-2850-9) |
| Marketing Start Date | 2023-09-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.11503 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | ALFUZOSIN HCL ER 10 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis